Wow, they seem to have jumped all over this very fast.
Just posting this Clinical Trial info. below as a follow up to the articles in a previous post which was...
HDC (Histidine Decarboxylase) gene
_____________
http://www.tsa-usa.org/aResearch/Saf...l_AZD5213.htmlSafety, Tolerability, Pharmacokinetic, and Efficacy of AZD5213 in Adolescents With Tourette's Disorder
Summit, NJ; Orange, CA; New York, NY; St. Petersburg, FL
http://clinicaltrials.gov/ct2/show/NCT01904773
Safety, Tolerability, Pharmacokinetic, and Efficacy Study of AZD5213 in Adolescents With Tourette's Disorder
This study is currently recruiting participants.
[Added note:
Sponsor:AstraZeneca]
_____________
http://www.prweb.com/releases/2014/03/prweb11637784.htm
March 05, 2014
- gives an explanation about how their drug targets histamine H3 receptor.
- dopamine regulation
_____________
I've just been doing some detective work and what do you know...
There's that T word again...
Targacept
AstraZeneca quietly sweeps out some notable mid-stage drug programs
February 6, 2014 | By John Carroll
http://www.fiercebiotech.com/story/a...ams/2014-02-06
_____________
Targacept
Quote:
Big Pharma and Big Tobacco share the same bed.
|
http://neurotalk.psychcentral.com/post829509-71.html
Regarding Mecamylamine/Inversine etc.
TC-5214